As of 2026-03-18, the Relative Valuation of Flexion Therapeutics Inc (FLXN) is (126.87) USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.37 USD, the upside of Flexion Therapeutics Inc based on Relative Valuation is -600.2%.
The range of the Relative Valuation is (114.62) - (130.88) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.4x - 25.4x | 23.2x |
| Forward P/E multiples | 20.4x - 23.3x | 22.1x |
| Fair Price | (114.62) - (130.88) | (126.87) |
| Upside | -551.9% - -616.0% | -600.2% |
| Date | P/E |
| 2026-03-13 | -4.47 |
| 2026-03-12 | -4.48 |
| 2026-03-11 | -4.52 |
| 2026-03-10 | -4.53 |
| 2026-03-09 | -4.53 |
| 2026-03-06 | -4.51 |
| 2026-03-05 | -4.53 |
| 2026-03-04 | -4.56 |
| 2026-03-03 | -4.54 |
| 2026-03-02 | -4.56 |
| 2026-02-27 | -4.55 |
| 2026-02-26 | -4.59 |
| 2026-02-25 | -4.59 |
| 2026-02-24 | -4.58 |
| 2026-02-23 | -4.58 |
| 2026-02-20 | -4.59 |
| 2026-02-19 | -4.58 |
| 2026-02-18 | -4.58 |
| 2026-02-17 | -4.58 |
| 2026-02-13 | -4.58 |
| 2026-02-12 | -4.58 |
| 2026-02-11 | -4.58 |
| 2026-02-10 | -4.58 |
| 2026-02-09 | -4.58 |
| 2026-02-06 | -4.58 |
| 2026-02-05 | -4.56 |
| 2026-02-04 | -4.56 |
| 2026-02-03 | -4.57 |
| 2026-02-02 | -4.58 |
| 2026-01-30 | -4.57 |
| 2026-01-29 | -4.56 |
| 2026-01-28 | -4.57 |
| 2026-01-27 | -4.57 |
| 2026-01-26 | -4.57 |
| 2026-01-23 | -4.57 |
| 2026-01-22 | -4.57 |
| 2026-01-21 | -4.57 |
| 2026-01-20 | -4.55 |
| 2026-01-16 | -4.56 |
| 2026-01-15 | -4.56 |
| 2026-01-14 | -4.56 |
| 2026-01-13 | -4.56 |
| 2026-01-12 | -4.55 |
| 2026-01-09 | -4.55 |
| 2026-01-08 | -4.55 |
| 2026-01-07 | -4.55 |
| 2026-01-06 | -4.55 |
| 2026-01-05 | -4.54 |
| 2026-01-02 | -4.53 |
| 2025-12-31 | -4.52 |